Skip to main content

Advertisement

Log in

Managing Pathologic Scars by Injecting Auto-Cross-linked Hyaluronic Acid: A Preliminary Prospective Clinical Study

  • Original Article
  • Non-Surgical Aesthetic
  • Published:
Aesthetic Plastic Surgery Aims and scope Submit manuscript

Abstract

Background

Pathological scars are unattractive and may significantly impair the patient’s quality of life. Current treatments provide inconsistent results, and none may be regarded as definitive. Recently, an auto-cross-linked hyaluronic acid (HA) formulation, IAL-SYSTEM ACP, featuring a long residence time and an enhanced safety profile, has been successfully used to prevent surgical adhesions, treat tendon lesions and rejuvenate the face and the décolletage. This study aims to preliminarily investigate whether IAL-SYSTEM ACP may also be effective in treating pathological scars resulting from burns, trauma or iatrogenic causes.

Methods

Patients presenting one pathological scar were prospectively recruited and treated with two IAL-SYSTEM ACP injections carried out two weeks apart. Scar improvement was measured comparing the patient and observer scar assessment scale (POSAS) scores collected before treatment (T0) and 90 days after the second injection (T90) using nonparametric tests. The effect of age and scar type over score variation was investigated through quantile regression analysis.

Results

Forty-one patients, 10 women and 31 men (median age, 34 years) were recruited. No patient dropped out, and no significant adverse event was observed. At T90, the median observer total score decreased by 11 units (− 77.5%) and the median patient total score decreased by 15 units (− 73.7%). The difference was significant (p < 0.001) in both cases. Traumatic injuries and young patient’s age were the most significant predictors of a positive treatment outcome.

Conclusions

Treatment of pathological scars by two IAL-SYSTEM ACP injections, carried out two weeks apart, may provide significant clinical benefits. These findings should be the subject of further investigations.

Level of Evidence IV

This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Tredget EE (1994) The molecular biology of fibroproliferative disorders of the skin: potential cytokine therapeutics. Ann Plast Surg 33(2):152–154

    CAS  PubMed  Google Scholar 

  2. Murray JC (1994) Keloids and hypertrophic scars. Clin Dermatol 12(1):27–37

    Article  CAS  PubMed  Google Scholar 

  3. Juckett G, Hartman-Adams H (2009) Management of keloids and hypertrophic scars. Am Fam Physician 80(3):253–260

    PubMed  Google Scholar 

  4. Ogawa R, Akaishi S, Hyakusoku H (2009) Differential and exclusive diagnosis of diseases that resemble keloids and hypertrophic scars. Ann Plast Surg 62(6):660–664

    Article  CAS  PubMed  Google Scholar 

  5. Ogawa R, Akaishi S, Izumi M (2009) Histologic analysis of keloids and hypertrophic scars. Ann Plast Surg 62(1):104–105

    Article  CAS  PubMed  Google Scholar 

  6. Broughton G 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117(7 Suppl):12S–34S

    Article  CAS  PubMed  Google Scholar 

  7. Enoch S, Leaper DJ (2008) Basic science of wound healing. Surgery 26(2):31–37

    Google Scholar 

  8. Martin P, Nunan R (2015) Cellular and molecular mechanisms of repair in acute and chronic wound healing. Br J Dermatol 173(2):370–378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sorg H, Tilkorn DJ, Hager S, Hauser J, Mirastschijski U (2017) Skin wound healing: an update on the current knowledge and concepts. Eur Surg Res 58(1–2):81–94

    Article  PubMed  Google Scholar 

  10. McDonald J, Hascall VC (2002) Hyaluronan minireview series. J Biol Chem 277(7):4575–4579

    Article  CAS  PubMed  Google Scholar 

  11. Dunphy JE (1978) Wound healing. Surg Clin North Am 58(5):907–916

    Article  CAS  PubMed  Google Scholar 

  12. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3(5):349–363

    Article  CAS  PubMed  Google Scholar 

  13. Jenkins RH, Thomas GJ, Williams JD, Steadman R (2004) Myofibroblastic differentiation leads to hyaluronan accumulation through reduced hyaluronan turnover. J Biol Chem 279(40):41453–41460

    Article  CAS  PubMed  Google Scholar 

  14. Ferguson EL, Roberts JL, Moseley R, Griffiths PC, Thomas DW (2011) Evaluation of the physical and biological properties of hyaluronan and hyaluronan fragments. Int J Pharm 420(1):84–92

    Article  CAS  PubMed  Google Scholar 

  15. Monslow J, Sato N, Mack JA, Maytin EV (2009) Wounding-induced synthesis of hyaluronic acid in organotypic epidermal cultures requires the release of heparin-binding egf and activation of the EGFR. J Invest Dermatol 129(8):2046–2058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Meyer LJ, Russell SB, Russell JD, Trupin JS, Egbert BM, Shuster S, Stern R (2000) Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol. 114(5):953–959

    Article  CAS  PubMed  Google Scholar 

  17. Sidgwick GP, Iqbal SA, Bayat A (2013) Altered expression of hyaluronan synthase and hyaluronidase mRNA may affect hyaluronic acid distribution in keloid disease compared with normal skin. Exp Dermatol 22(5):377–379

    Article  CAS  PubMed  Google Scholar 

  18. Bertheim U, Hellström S (1994) The distribution of hyaluronan in human skin and mature, hypertrophic and keloid scars. Br J Plast Surg 47(7):483–489

    Article  CAS  PubMed  Google Scholar 

  19. Ogawa R, Akaishi S, Huang C, Dohi T, Aoki M, Omori Y, Koike S, Kobe K, Akimoto M, Hyakusoku H (2011) Clinical applications of basic research that shows reducing skin tension could prevent and treat abnormal scarring: the importance of fascial/subcutaneous tensile reduction sutures and flap surgery for keloid and hypertrophic scar reconstruction. J Nippon Med Sch 78(2):68–76

    Article  PubMed  Google Scholar 

  20. Moio M, Mataro I, Accardo G, Canta L, Schonauer F (2014) Treatment of hypergranulation tissue with intralesional injection of corticosteroids: preliminary results. J Plast Reconstr Aesthet Surg 67(6):e167–e168

    Article  PubMed  Google Scholar 

  21. Roques C, Téot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7(3):137–145

    Article  PubMed  Google Scholar 

  22. De Cicco L, Vischioni B, Vavassori A, Gherardi F, Jereczek-Fossa BA, Lazzari R, Cattani F, Comi S, De Lorenzi F, Martella S, Orecchia R (2014) Postoperative management of keloids: low-dose-rate and high-dose-rate brachytherapy. Brachytherapy 13(5):508–513

    Article  PubMed  Google Scholar 

  23. Chang P, Laubenthal KN, Lewis RW 2nd, Rosenquist MD, Lindley-Smith P, Kealey GP (1995) Prospective, randomized study of the efficacy of pressure garment therapy in patients with burns. J Burn Care Rehabil 16(5):473–475

    Article  CAS  PubMed  Google Scholar 

  24. Maján JI (2006) Evaluation of a self-adherent soft silicone dressing for the treatment of hypertrophic postoperative scars. J Wound Care 15(5):193–196

    Article  PubMed  Google Scholar 

  25. Khan MA, Bashir MM, Khan FA (2014) Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc 64(9):1003–1007

    PubMed  Google Scholar 

  26. Carroll W, Patel K (2015) Steroids and fluorouracil for keloids and hypertrophic scars. JAMA Facial Plast Surg 17(2):77–79

    Article  PubMed  Google Scholar 

  27. Haurani MJ, Foreman K, Yang JJ, Siddiqui A (2009) 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 123(1):139–148

    Article  CAS  PubMed  Google Scholar 

  28. Payapvipapong K, Niumpradit N, Piriyanand C, Buranaphalin S, Nakakes A (2015) The treatment of keloids and hypertrophic scars with intralesional bleomycin in skin of color. J Cosmet Dermatol 14(1):83–90

    Article  PubMed  Google Scholar 

  29. Wang R, Mao Y, Zhang Z, Li Z, Chen J, Cen Y (2016) Role of verapamil in preventing and treating hypertrophic scars and keloids. Int Wound J. 13(4):461–468

    Article  PubMed  Google Scholar 

  30. Brewin MP, Lister TS (2014) Prevention or treatment of hypertrophic burn scarring: a review of when and how to treat with the pulsed dye laser. Burns 40(5):797–804

    Article  CAS  PubMed  Google Scholar 

  31. Nicoletti G, De Francesco F, Mele CM, Cataldo C, Grella R, Brongo S, Accardo M, Ferraro GA, D’Andrea F (2013) Clinical and histologic effects from CO2 laser treatment of keloids. Lasers Med Sci 28(3):957–964

    Article  PubMed  Google Scholar 

  32. Scrimali L, Lomeo G, Nolfo C, Pompili G, Tamburino S, Catalani A, Siragò P, Perrotta RE (2010) Treatment of hypertrophic scars and keloids with a fractional CO2 laser: a personal experience. J Cosmet Laser Ther 12(5):218–221

    Article  PubMed  Google Scholar 

  33. Camacho-Martínez FM, Rey ER, Serrano FC, Wagner A (2013) Results of a combination of bleomycin and triamcinolone acetonide in the treatment of keloids and hypertrophic scars. An Bras Dermatol 88(3):387–394

    Article  PubMed  PubMed Central  Google Scholar 

  34. Darougheh A, Asilian A, Shariati F (2009) Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 34(2):219–223

    Article  CAS  PubMed  Google Scholar 

  35. Martin MS, Collawn SS (2013) Combination treatment of CO2 fractional laser, pulsed dye laser, and triamcinolone acetonide injection for refractory keloid scars on the upper back. J Cosmet Laser Ther 15(3):166–170

    Article  PubMed  Google Scholar 

  36. Liu S, Jiang L, Li H, Shi H, Luo H, Zhang Y, Yu C, Jin Y (2014) Mesenchymal stem cells prevent hypertrophic scar formation via inflammatory regulation when undergoing apoptosis. J Invest Dermatol 134(10):2648–2657

    Article  CAS  PubMed  Google Scholar 

  37. Seo BF, Jung SN (2016) The immunomodulatory effects of mesenchymal stem cells in prevention or treatment of excessive scars. Stem Cells Int 2016:6937976

    Article  PubMed  CAS  Google Scholar 

  38. Svolacchia F, De Francesco F, Trovato L, Graziano A, Ferraro GA (2016) An innovative regenerative treatment of scars with dermal micrografts. J Cosmet Dermatol 15(3):245–253

    Article  PubMed  Google Scholar 

  39. Zhang Q, Liu LN, Yong Q, Deng JC, Cao WG (2015) Intralesional injection of adipose-derived stem cells reduces hypertrophic scarring in a rabbit ear model. Stem Cell Res Ther 18(6):145

    Article  CAS  Google Scholar 

  40. Brongo S, Nicoletti GF, La Padula S, Mele CM, DʼAndrea F (2012) Use of lipofilling for the treatment of severe burn outcomes. Plast Reconstr Surg 130(2):374e–376e

    Article  CAS  PubMed  Google Scholar 

  41. Brunelli G, Longinotti C, Bertazzo C, Pavesio A, Pressato D (2005) Adhesion reduction after knee surgery in a rabbit model by Hyaloglide, a hyaluronan derivative gel. J Orthop Res 23(6):1377–1382

    CAS  PubMed  Google Scholar 

  42. Abate M, Schiavone C, Salini V (2014) The use of hyaluronic acid after tendon surgery and in tendinopathies. Biomed Res Int 2014:783632

    Article  PubMed  PubMed Central  Google Scholar 

  43. Matarasso SL (2004) Understanding and using hyaluronic acid. Aesthet Surg J 24(4):361–364

    Article  PubMed  Google Scholar 

  44. Tezel A, Fredrickson GH (2008) The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 10(1):35–42. Erratum in: J Cosmet Laser Ther. 2014 16(1):45

  45. Pluda S, Pavan M, Galesso D, Guarise C (2016) Hyaluronic acid auto-crosslinked polymer (ACP): reaction monitoring, process investigation and hyaluronidase stability. Carbohydr Res 4(433):47–53

    Article  CAS  Google Scholar 

  46. de Wit T, de Putter D, Tra WM, Rakhorst HA, van Osch GJ, Hovius SE, van Neck JW (2009) Auto-crosslinked hyaluronic acid gel accelerates healing of rabbit flexor tendons in vivo. J Orthop Res 27(3):408–415

    Article  PubMed  Google Scholar 

  47. Belluco C, Meggiolaro F, Pressato D, Pavesio A, Bigon E, Donà M, Forlin M, Nitti D, Lise M (2001) Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel. J Surg Res 100(2):217–221

    Article  CAS  PubMed  Google Scholar 

  48. Guida M, Acunzo G, Di Spiezio Sardo A, Bifulco G, Piccoli R, Pellicano M, Cerrota G, Cirillo D, Nappi C (2004) Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod 19(6):1461–1464

    Article  CAS  PubMed  Google Scholar 

  49. Smit X, van Neck JW, Afoke A, Hovius SE (2004) Reduction of neural adhesions by biodegradable autocrosslinked hyaluronic acid gel after injury of peripheral nerves: an experimental study. J Neurosurg 101(4):648–652

    Article  CAS  PubMed  Google Scholar 

  50. Atzei A, Calcagni M, Breda B, Fasolo G, Pajardi G, Cugola L (2007) Clinical evaluation of a hyaluronan-based gel following microsurgical reconstruction of peripheral nerves of the hand. Microsurgery 27(1):2–7

    Article  PubMed  Google Scholar 

  51. Riccio M, Battiston B, Pajardi G, Corradi M, Passaretti U, Atzei A, Altissimi M, Vaienti L, Catalano F, Del Bene M, Fasolo P, Ceruso M, Luchetti R, Landi A; Study Group on Tendon Adhesion of Italian Society of Hand Surgery (2010) Efficiency of hyaloglide in the prevention of the recurrence of adhesions after tenolysis of flexor tendons in zone II: a randomized, controlled, multicentre clinical trial. J Hand Surg Eur 35(2):130–138

    Article  Google Scholar 

  52. Alessandrini A, Di Bartolo C, Pavesio A, Pressato D (2006) ACP gel: a new hyaluronic acid-based injectable for facial rejuvenation. Preclinical data in a rabbit model. Plast Reconstr Surg 118(2):341–346

    Article  CAS  PubMed  Google Scholar 

  53. Alessandrini A, Tretyakova K (2018) The rejuvenating effect and tolerability of an auto-cross-linked hyaluronic acid on décolletage: a pilot prospective study. Aesthetic Plast Surg 42(2):520–529

    Article  PubMed  Google Scholar 

  54. Renier D, Bellato P, Bellini D, Pavesio A, Pressato D, Borrione A (2005) Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration. Biomaterials 26(26):5368–5374

    Article  CAS  PubMed  Google Scholar 

  55. Wohlrab J, Wohlrab D, Neubert RH (2013) Comparison of noncross-linked and cross-linked hyaluronic acid with regard to efficacy of the proliferative activity of cutaneous fibroblasts and keratinocytes in vitro. J Cosmet Dermatol 12(1):36–40

    Article  PubMed  Google Scholar 

  56. van de Kar AL, Corion LU, Smeulders MJ, Draaijers LJ, van der Horst CM, van Zuijlen PP (2005) Reliable and feasible evaluation of linear scars by the patient and observer scar assessment scale. Plast Reconstr Surg 116(2):514–522

    Article  PubMed  CAS  Google Scholar 

  57. Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, van Zuijlen PP (2004) The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 113(7):1960–1965

    Article  PubMed  Google Scholar 

  58. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available from https://www.R-project.org/. Accessed 19 December 2017

  59. Bell L, McAdams T, Morgan R, Parshley PF, Pike RC, Riggs P, Carpenter JE (1988) Pruritus in burns: a descriptive study. J Burn Care Rehabil 9(3):305–308

    Article  CAS  PubMed  Google Scholar 

  60. Bakker A, Maertens KJ, Van Son MJ, Van Loey NE (2013) Psychological consequences of pediatric burns from a child and family perspective: a review of the empirical literature. Clin Psychol Rev 33(3):361–371

    Article  PubMed  Google Scholar 

  61. Sund B (2000) New developments in wound care. PJB Publications, London. pp 1–255. (Clinical Report CBS 836.)

  62. Van Loey NE, Bremer M, Faber AW, Middelkoop E, Nieuwenhuis MK (2008) Itching following burns: epidemiology and predictors. Br J Dermatol 158(1):95–100

    PubMed  Google Scholar 

  63. Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E (2009) Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen 17(5):649–656

    Article  PubMed  Google Scholar 

  64. Gebhardt C, Averbeck M, Diedenhofen N, Willenberg A, Anderegg U, Sleeman JP, Simon JC (2010) Dermal hyaluronan is rapidly reduced by topical treatment with glucocorticoids. J Invest Dermatol 130(1):141–149

    Article  CAS  PubMed  Google Scholar 

  65. Aya KL, Stern R (2014) Hyaluronan in wound healing: rediscovering a major player. Wound Repair Regen 22(5):579–593

    Article  PubMed  Google Scholar 

  66. King SR, Hickerson WL, Proctor KG (1991) Beneficial actions of exogenous hyaluronic acid on wound healing. Surgery 109(1):76–84

    CAS  PubMed  Google Scholar 

  67. Hoffmann A, Hoing JL, Newman M, Simman R (2013) Role of hyaluronic acid treatment in the prevention of Keloid scarring. J Am Coll Clin Wound Spec. 4(2):23–31

    Article  PubMed  PubMed Central  Google Scholar 

  68. Soranzo C, Renier D, Pavesio A (2004) Synthesis and characterization of hyaluronan-based polymers for tissue engineering. Methods Mol Biol 238:25–40

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesco De Francesco.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

All subjects provide their informed consent.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Riccio, M., Marchesini, A., Senesi, L. et al. Managing Pathologic Scars by Injecting Auto-Cross-linked Hyaluronic Acid: A Preliminary Prospective Clinical Study. Aesth Plast Surg 43, 480–489 (2019). https://doi.org/10.1007/s00266-018-01303-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00266-018-01303-3

Keywords

Navigation